Clinical Trial Update: Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating megestrol acetate plus LNG-IUS in young women with early-stage endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Neoplasm - Malignant

Drugs mentioned

• LNG-IUS (levonorgestrel-releasing intrauterine system)
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Fudan University | Conditions: Endometrial Neoplasm Malignant Stage I | Phase 2, Phase 3 | Status: COMPLETED